Clinical Trial Update: The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion [NA]

View source ↗

Summary

A completed clinical trial investigated whether inhibition of HMG-CoA reductase (statins) influences postprandial GLP-1 secretion in people with Type 2 diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Statins

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Diabetes Mellitus, Type 2, Hydroxymethylglutaryl-CoA Reductase Inhibitors | NA | Status: COMPLETED